Leveraging multiple external partners, a leading clinical-stage biotechnology company manufactures AAV viral vectors as part of its proprietary gene delivery platform.
Novavax has more than a decade of experience contending with some of the world’s most devastating diseases, including seasonal influenza, RSV, Ebola, MERS, and SARS
Global biotech company committed to discovering and developing solutions for some of the most unmet medical needs with research that spans oncology, inflammation and autoimmunity
The customer excels at translating scientific research into clinically actionable test results.Â
